HTK vs. HTK-N for Coronary Endothelial Protection during Hypothermic, Oxygenated Perfusion of Hearts Donated after

Lars Saemann1,2, Kristin Wächter1, Nitin Gharpure1

  • 1Department of Cardiac Surgery, University Hospital Halle (Saale), University of Halle, 06120 Halle (Saale), Germany.

Insights

The novel HTK-N solution better preserves coronary artery endothelial function in donation-after-circulatory-death (DCD) donor hearts compared to traditional HTK solution during hypothermic oxygenated perfusion (HOP). This improved preservation may reduce allograft vasculopathy risk.

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Vascular Biology

Background:

  • Coronary artery protection is crucial for donor heart maintenance and preventing allograft vasculopathy.
  • While hypothermic, oxygenated perfusion (HOP) effects on microvasculature are known, macrovasculature impact remains unclear.
  • Donation-after-circulatory-death (DCD) hearts present unique preservation challenges.

Purpose of the Study:

  • To investigate the effect of a novel HTK-N solution versus traditional HTK solution on the coronary macrovasculature of DCD porcine hearts during HOP.
  • To compare endothelial-dependent and -independent vasomotor function of the left anterior descending coronary artery (LAD) post-perfusion.
  • To analyze the transcriptome of LAD samples to understand underlying molecular mechanisms.

Main Methods:

  • Porcine DCD hearts were preserved using HOP with either HTK or HTK-N for 4 hours.
  • Hearts underwent 2 hours of transplantation-equivalent reperfusion with blood.
  • Vasomotor function (bradykinin, sodium-nitroprusside) and LAD transcriptome (microarrays) were assessed.

Main Results:

  • HTK-N significantly improved endothelial-dependent relaxation compared to HTK.
  • Endothelial-independent relaxation was comparable between groups.
  • Transcriptome analysis revealed HTK-N upregulated genes involved in cell preservation and downregulated those related to ischemia/reperfusion injury and immune response.

Conclusions:

  • The novel HTK-N solution offers superior preservation of coronary artery endothelial function in DCD donor hearts compared to the traditional HTK solution.
  • HTK-N's molecular profile suggests enhanced protection against ischemia/reperfusion injury and improved vascular health.
  • These findings support HTK-N as a promising preservation solution for DCD donor hearts.

Related Concept Videos